Literature DB >> 24648811

Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma.

Ha-young Lee1, Kyung Hee Lee2, Myung Soo Hyun2, Min Kyoung Kim2, Sung Ae Koh2, Hee Soon Cho3.   

Abstract

Entities:  

Keywords:  Chronic myeloid leukemia; Diffuse large B-cell lymphoma; Therapy-related

Mesh:

Substances:

Year:  2014        PMID: 24648811      PMCID: PMC3956998          DOI: 10.3904/kjim.2014.29.2.250

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


× No keyword cloud information.
  5 in total

Review 1.  Treatment-related chronic myelogenous leukemia.

Authors:  C F Waller; S Fetscher; W Lange
Journal:  Ann Hematol       Date:  1999-08       Impact factor: 3.673

2.  Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.

Authors:  Richard A Larson; Michelle M Le Beau
Journal:  Chem Biol Interact       Date:  2005-04-13       Impact factor: 5.192

3.  Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.

Authors:  H M Kantarjian; M J Keating; R S Walters; T L Smith; A Cork; K B McCredie; E J Freireich
Journal:  J Clin Oncol       Date:  1986-12       Impact factor: 44.544

4.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

Authors:  D L Preston; S Kusumi; M Tomonaga; S Izumi; E Ron; A Kuramoto; N Kamada; H Dohy; T Matsuo; T ] Matsui T [corrected to Matsuo
Journal:  Radiat Res       Date:  1994-02       Impact factor: 2.841

Review 5.  Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal.

Authors:  R C Aguiar
Journal:  Leuk Lymphoma       Date:  1998-03
  5 in total
  1 in total

1.  A Case of Preleukemic Chronic Myeloid Leukemia Following Chemotherapy and Autologous Transplantation for T-lymphoblastic Lymphoma.

Authors:  Hyunji Choi; Sung Ran Cho; Dahae Yang; Woonhyoung Lee; Hyunyong Hwang; Ho Sup Lee; Da Jung Kim; Taeyun Kim; Mi Hyang Kim
Journal:  Ann Lab Med       Date:  2020-09       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.